Department of Pharmacology, School of Pharmaceutical Science, Central South University, Changsha, Hunan, China.
Pharmacogenet Genomics. 2011 Mar;21(3):142-51. doi: 10.1097/FPC.0b013e328343ea0a.
To determine whether functional polymorphisms of glutathione S-transferase μ type 1 (GSTM1) and aldehyde dehydrogenase-2 (ALDH2) affect the isosorbide 5-mononitrate (IS-5-MN) response, and the role of the calcitonin gene-related peptide (CGRP) in IS-5-MN response in healthy volunteers.
A two-phase, placebo-controlled study was carried out in 24 healthy Chinese volunteers with their ALDH2 and GSTM1 genotypes known. During each phase, either 20-mg IS-5-MN tablet or placebo was orally administered; blood pressure (BP), heart rate, and plasma concentration of CGRP was determined before and at several time points after drug administration. Pharmacokinetic parameters of IS-5-MN were determined.
GSTM1 null individuals showed significantly lower systolic BP (SBP) and diastolic BP (DBP), and higher degree of decreases in SBP (ΔSBP) and DBP (ΔDBP) after IS-5-MN administration. GSTM1 null individuals showed significantly decreased IS-5-MN area under the plasma concentration-time curve than GSTM1 wild-type individuals (P<0.05). Plasma concentration of CGRP was increased significantly at 0.5 (P<0.01), 1 (P<0.05), and 2 h (P<0.05) after IS-5-MN administration in GSTM1 null individuals but not wild-type individuals. GSTM1 null individuals also showed significantly higher degree of percentage increase in the plasma concentration of CGRP than GSTM1 wild-type individuals at 1 h after IS-5-MN administration (P<0.05). IS-5-MN upregulated CGRP I and CGRP II mRNA expressions in cultured peripheral blood mononuclear cells, and the IS-5-MN-induced CGRP II mRNA expression was inhibited by GSTs inhibitor, ethacrynic acid. No difference in the IS-5-MN response was observed between ALDH2 genotypes.
We suggest that GSTM1, but not ALDH2, may interfere with the bioactivation of IS-5-MN, and CGRP contributes to the IS-5-MN response in a GSTM1 genotype-dependent manner.
确定谷胱甘肽 S-转移酶 μ 型 1(GSTM1)和醛脱氢酶-2(ALDH2)的功能多态性是否影响异山梨醇 5-单硝酸酯(IS-5-MN)的反应,以及降钙素基因相关肽(CGRP)在健康志愿者中对 IS-5-MN 反应的作用。
在已知其 ALDH2 和 GSTM1 基因型的 24 名健康中国志愿者中进行了两阶段、安慰剂对照研究。在每个阶段,志愿者分别口服 20mg 的 IS-5-MN 片剂或安慰剂;在给药前和给药后多个时间点测定血压(BP)、心率和血浆 CGRP 浓度。测定 IS-5-MN 的药代动力学参数。
GSTM1 缺失个体在服用 IS-5-MN 后,收缩压(SBP)和舒张压(DBP)明显降低,SBP(ΔSBP)和 DBP(ΔDBP)下降幅度更大。与 GSTM1 野生型个体相比,GSTM1 缺失个体的 IS-5-MN 血浆浓度-时间曲线下面积明显降低(P<0.05)。GSTM1 缺失个体在服用 IS-5-MN 后 0.5(P<0.01)、1(P<0.05)和 2(P<0.05)h 时,血浆 CGRP 浓度明显升高,但 GSTM1 野生型个体无此变化。与 GSTM1 野生型个体相比,GSTM1 缺失个体在服用 IS-5-MN 后 1h 时,血浆 CGRP 浓度的百分比增加程度明显更高(P<0.05)。IS-5-MN 可上调培养外周血单核细胞中 CGRP I 和 CGRP II mRNA 的表达,GSTs 抑制剂乙二醛酸可抑制 IS-5-MN 诱导的 CGRP II mRNA 表达。ALDH2 基因型对 IS-5-MN 反应无差异。
我们认为 GSTM1 而不是 ALDH2 可能干扰 IS-5-MN 的生物活化,CGRP 以 GSTM1 基因型依赖性方式参与 IS-5-MN 的反应。